The global demand for Biopharmaceutical Contract Manufacturing Market is presumed to reach the market size of nearly USD 20.14 MN by 2028 from USD 9.4 MN in 2021 with a CAGR of 11.5% under the study period 2022 - 2028.
Biopharmaceutical contract manufacturing, otherwise called outsourcing, is employed when pharmaceutical manufacturers avail the facilities of other companies for producing drugs under their brand. Biopharmaceutical contract manufacturing is quite resembling third-party manufacturing or private label manufacturing. Biopharmaceutical contract manufacturing can be processed for either biopharma drugs or synthetic drugs. The services delivered by biopharmaceutical contract manufacturing are not limited to manufacturing but consist of the development of compliance documents, drug stability studies as per FDA regulatory requirements, expanding late-stage clinical trial samples, offering scale-up and registration batches, and pre-formulation.
Market Dynamics
The global biopharmaceutical contract manufacturing is expanding at a healthy rate during the forecast period. The rise in the volume of outsourcing for drug manufacturing to the contract manufacturers by the well-known biopharmaceutical drug producers as well as start-up organizations to prevent some costly expenditures like expertise to drive regulatory concerns, the cost of generic manufacturing equipment, and others are projected to boost the biopharmaceutical contract manufacturing market growth globally. The global biopharmaceuticals contract manufacturing market is expected to witness prominent growth due to the increase in the need for contract manufacturing by the major biopharmaceutical organizations, increasing concern on contract manufacturing organizations in propelling their capabilities to produce biological drugs, and the existence of a strong biologic pipeline among numerous businesses worldwide are all contributing to the biopharmaceutical contract manufacturing market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biopharmaceutical contract manufacturing. The growth and trends of biopharmaceutical contract manufacturing industry provide a holistic approach to this study.
Market Segmentation
This section of the biopharmaceutical contract manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Growth Factors
- Interferons
- Monoclonal Antibodies
- Recombinant Hormones
- Vaccines
- Insulin
- Others
By Application
- Autoimmune Diseases
- Oncology
- Metabolic Diseases
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Biopharmaceutical Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Biopharmaceutical Contract Manufacturing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biopharmaceutical contract manufacturing market include Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva, Probiogen, Cytovance Biologics, KBI Biopharma, WuXi Biologics, Abzena. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.